Literature DB >> 622555

Lichen myxedematosus serum stimulates human skin fibroblast proliferation.

R A Harper, J Rispler.   

Abstract

Serum from patients with lichen myxedematosus, when added to exponentially growing normal human skin fibroblasts, stimulates DNA synthesis and cell proliferation. The degree of response in vitro is correlated with the extent of the disease in vivo and is specific for fibroblasts. The results suggest that there is a systemic factor (or factors) which may play a role in the etiology of diseases affecting the connective tissue.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622555     DOI: 10.1126/science.622555

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  Scleromyxoedema with features of systemic sclerosis.

Authors:  U N Verma; R R Singh; R Misra; S Naik; S S Agarwal
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

3.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

4.  Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Authors:  Michele L Donato; Adrienne M Feasel; Donna M Weber; Victor G Prieto; Sergio A Giralt; Richard E Champlin; Madeleine Duvic
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

Review 5.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

6.  Papular mucinosis, destructive arthropathy, median neuropathy, and sicca complex.

Authors:  R A Frayha
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

Review 7.  Scleroderma-like fibrosing disorders.

Authors:  Francesco Boin; Laura K Hummers
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

8.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

9.  Periadnexal mucin as an additional histopathologic feature of chronic eczematous dermatitis.

Authors:  Noo Ri Lee; Jae-Hong Kim; Hwa-Young Park; Na Young Yoon; Sung Ku Ahn
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

10.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.